Article
Enhancing Pharmacy Oversight And Auditing Practices
The following discussion highlights key compliance considerations for both existing pharmacies...
Ankura Consulting Group LLC
United States: Food, Drugs, Healthcare, Life Sciences
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
The future of the robotics metaverse in the healthcare sector
On February 26, 2025, the European Economic and Social Committee (EESC) adopted an opinion addressing the integration of robotics and the metaverse in healthcare.
A&O Shearman
Article
Podcast - Innovations And Insights In The Palliative Care Space
In this episode of "Counsel That Cares," Daniel Patten, a partner in Holland & Knight's Healthcare Regulatory & Enforcement Practice, and Spencer Freeman...
Holland & Knight
Article
Former FDA Officials Howard Sklamberg And Eva Temkin Share Insights On AI's Role In Drug Development On FDA Watch Podcast
Life Sciences & Healthcare Regulatory partners and former FDA officials Howard Sklamberg and Eva Temkin were featured in FDA Watch's podcast series...
Arnold & Porter
Article
Reflections On The FDLI 2025 Annual Conference – Differing Tones, Shared Goals
Sheppard Mullin Richter & Hampton
Article
New York State Department Of Health Publishes Form Of Material Transactions Notice
Holland & Knight
Article
It's A Bird, It's A Plane, It's An UPDATE On Operation Stork Speed
Hyman, Phelps, & McNamara
Article
Commissioner Makary Charts A New Course For FDA At FDLI Annual Conference
Hyman, Phelps, & McNamara
Article
Speaker Programs: Two Recent Enforcement Actions Serve As A Reminder Of The Government's Longstanding Scrutiny
Mintz
Article
Indiana Legislative Update: No New Health Care Merger Approval Board, But Some New Reporting Requirements For Health Care Entities
Taft Stettinius & Hollister
Article
Recent Developments In PFAS Litigation
Thompson Coburn LLP
Article
Pharmacies On Alert: Gilead Reports Pharmacies To State Boards Over Counterfeit Drug Purchases
Buchanan Ingersoll & Rooney PC
Article
Drug Pricing: Trump Signs "Most Favored Nation" Executive Order
Foley & Lardner
Article
President Trump Issues Two Executive Orders Concerning The Affordability And Accessibility Of Drugs
Goodwin Procter LLP
Article
Tentative List Of Countries For Potential Travel Ban And Travel Restrictions
Pryor Cashman LLP
Curated
Why Direct Student-Athlete Payments Create An Immigration Crisis For Universities
Green and Spiegel
Curated
America's Misunderstood Trade Deficit
Braumiller Law Group, PLLC
Curated
DOJ Memo Previews Immigration Enforcement Actions
Green and Spiegel
Curated
Tariffs, Contracts And The Negotiation Imperative: Why The Old Playbook Won't Work
JAMS
Highlighted Content
Curated
Plausibility At The EPO – An Update On G2/21
Dehns
Curated
Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?
Dehns
Curated
Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?
Dehns
Curated
How Good Does A Copy Need To Be?
Dehns
Curated
Supplementary Protection Certificates – European Patent Term Extensions
Dehns
Curated
How Much Experimental Data Is Needed For Patent Applications In Europe?
Dehns
Curated
The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects
Dehns
Curated
Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector
Dehns
Curated
Protection For Plant Varieties In Europe And The UK Post-Brexit
Dehns
Curated
Best Practice For Invention Harvesting
Dehns
Article
Former FDA Officials Howard Sklamberg And Eva Temkin Share Insights On AI's Role In Drug Development On FDA Watch Podcast
Life Sciences & Healthcare Regulatory partners and former FDA officials Howard Sklamberg and Eva Temkin were featured in FDA Watch's podcast series...
Arnold & Porter
Article
The New Antitrust Frontier: How The "Most-Favored Nation" (MFN) Executive Order Targets Drug Pricing Power
In a marked shift toward competition-focused healthcare policy, the latest Executive Order on drug pricing reflects the Administration's expanding use of antitrust tools to address high pharmaceutical costs.
Winston & Strawn LLP
Article
Reflections On The FDLI 2025 Annual Conference – Differing Tones, Shared Goals
To be sure, much of what was said (aside from Dr. Makary's now widely reported-on comment about a new vaccine framework) was not new, but there are a number of industry takeaways when viewed together and in the context of the conference itself.
Sheppard Mullin Richter & Hampton
Article
It's A Bird, It's A Plane, It's An UPDATE On Operation Stork Speed
Hyman, Phelps, & McNamara
Article
Commissioner Makary Charts A New Course For FDA At FDLI Annual Conference
Hyman, Phelps, & McNamara
Article
"AI Policy Roadmap" Released By AdvaMed To Guide Regulators
Foley & Lardner
Article
Recent Developments In PFAS Litigation
Thompson Coburn LLP
Article
Pharmacies On Alert: Gilead Reports Pharmacies To State Boards Over Counterfeit Drug Purchases
Buchanan Ingersoll & Rooney PC
Article
Drug Pricing: Trump Signs "Most Favored Nation" Executive Order
Foley & Lardner
Article
Enhancing Pharmacy Oversight And Auditing Practices
The following discussion highlights key compliance considerations for both existing pharmacies...
Ankura Consulting Group LLC
Article
The future of the robotics metaverse in the healthcare sector
On February 26, 2025, the European Economic and Social Committee (EESC) adopted an opinion addressing the integration of robotics and the metaverse in healthcare.
A&O Shearman
Article
Former FDA Officials Howard Sklamberg And Eva Temkin Share Insights On AI's Role In Drug Development On FDA Watch Podcast
Life Sciences & Healthcare Regulatory partners and former FDA officials Howard Sklamberg and Eva Temkin were featured in FDA Watch's podcast series...
Arnold & Porter
Article
Reflections On The FDLI 2025 Annual Conference – Differing Tones, Shared Goals
Sheppard Mullin Richter & Hampton
Article
Speaker Programs: Two Recent Enforcement Actions Serve As A Reminder Of The Government's Longstanding Scrutiny
Mintz
Article
Twenty States Sue The Trump Administration For HHS Program Eliminations And Staff Layoffs
Mintz
Article
Mitigating Commercial Contracting Risk In Uncertain Times
Arnold & Porter
Article
Holland & Knight Health Dose: May 13, 2025
Holland & Knight
Article
Texas House Passes Psychedelics Bills Aimed At Expediting Access To Psychedelic Therapy
Buchanan Ingersoll & Rooney PC
Article
Enhancing Pharmacy Oversight And Auditing Practices
The following discussion highlights key compliance considerations for both existing pharmacies...
Ankura Consulting Group LLC
Article
The future of the robotics metaverse in the healthcare sector
On February 26, 2025, the European Economic and Social Committee (EESC) adopted an opinion addressing the integration of robotics and the metaverse in healthcare.
A&O Shearman
Article
Podcast - Innovations And Insights In The Palliative Care Space
In this episode of "Counsel That Cares," Daniel Patten, a partner in Holland & Knight's Healthcare Regulatory & Enforcement Practice, and Spencer Freeman...
Holland & Knight
Article
Former FDA Officials Howard Sklamberg And Eva Temkin Share Insights On AI's Role In Drug Development On FDA Watch Podcast
Arnold & Porter
Article
Reflections On The FDLI 2025 Annual Conference – Differing Tones, Shared Goals
Sheppard Mullin Richter & Hampton
Article
New York State Department Of Health Publishes Form Of Material Transactions Notice
Holland & Knight
Article
It's A Bird, It's A Plane, It's An UPDATE On Operation Stork Speed
Hyman, Phelps, & McNamara
Article
"AI Policy Roadmap" Released By AdvaMed To Guide Regulators
Foley & Lardner
Article
Speaker Programs: Two Recent Enforcement Actions Serve As A Reminder Of The Government's Longstanding Scrutiny
Mintz
Article
The "Lead Compound" Approach To Obviousness And Obviousness-Type Double Patenting
In Otsuka Pharmaceutical Co. v. Sandoz, Inc., the Federal Circuit upheld the district court’s determination that the claims at issue were neither obvious nor invalid under the doctrine of obviousness-type double patenting based on a "lead compound" approach to the obviousness determinations.
Foley & Lardner
Article
With Ultramercial Remand, Is The Supreme Court Telegraphing View On Patent Eligibility To Federal Circuit?
After the Supreme Court decided that the personalized medicine method claims at issue in Mayo Collaborative Services v. Prometheus Laboratories, Inc. did not satisfy the patent eligibility requirements of 35 USC § 101.
Foley & Lardner
Article
GSK And Genentech Settle Cabilly Patent Lawsuit
GlaxoSmithKline and Genentech have settled a U.S. lawsuit related to Genentech's Cabilly II (US 6,331,415) and Cabilly III (US 7,923,221) patents.
Beeser Ramamoorthy LLP
Article
Supreme Court Holds That Generic Drug Manufacturers Can Challenge The Validity Of A Reference Drug’s "Use Code"
Bradley Arant Boult Cummings LLP
Article
U.S. Supreme Court Allows Generic Drug Manufacturers To Challenge Brand’s FDA Use Codes
Vinson & Elkins LLP
Article
Supreme Court Allows Generics To Challenge Orange Book Use Codes In Hatch-Waxman Litigation
Paul Hastings LLP
Article
Supreme Court Sides With Generic Drug Manufacturers, Closes Loophole In Hatch-Waxman Act
Perkins Coie LLP
Article
U.S. Supreme Court Remands Myriad Case In Light Of Its Decision In Prometheus
Vinson & Elkins LLP
Article
Federal Circuit Articulates Facts Establishing Jurisdiction In Declaratory Judgment Actions
Vinson & Elkins LLP
See more
Navigating FDA Compliance And Civil Litigation: Strategies For Food And Medical Product Companies (Video)
Arnold & Porter
Artificial Intelligence In Healthcare (Video)
Buchanan Ingersoll & Rooney PC
DSO Market Trends And 2025 Outlook ADSO Webinar Recording (Video)
Benesch Friedlander Coplan & Aronoff LLP
Safeguarding Trust: Preventing Theft In Assisted Living Facilities (Video)
Jackson Lewis P.C.
Life Science Dealmaking Trends 2025 (Video)
Mintz